- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02483806
Effects of Positive End-Expiratory Pressure on Biventricular Function During One-Lung Ventilation
December 26, 2017 updated by: Yonsei University
Effects of Positive End-Expiratory Pressure on Biventricular Function During One-Lung Ventilation: a Randomized Crossover Study
One lung ventilation (OLV) is essential during thoracic surgery.
During OLV, intrapulmonary shunt can be increased resulting hypoxemia.
Wang et al measured intrapulmonary shunt by transesophageal echocardiography.
Although OLV technique had been advanced so far, hypoxemia during OLV reaches about 10% in spite of inspired oxygen fraction 100%.
Applying PEEP(Positive End-expiratory Pressure) at dependent lung and CPAP at non-dependent lung can mitigate the hypoxemia.
Above all, PEEP can be easily applicable.
However, there are controversial studies whether it is supportive or not.
In this prospective, cross-over study, the investigators are planning to investigate the effects of PEEP on intrapulmonary shunt, oxygenation and cardiac function as well.
Study Overview
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 120-752
- Department of Anaesthesiology and Pain Medicine, Anaesthesia and Pain Research Institute, Yonsei University College of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- scheduled for VATS lobectomy
- 40 ≤ age ≤ 80
- American Society of Anaesthesiologists(ASA) physical status classification I~III
Exclusion Criteria:
- American Society of Anaesthesiologists(ASA) physical status classification IV
- NYHA class III~IV
- Severe obstructive lung disease and/or restrictive lung disease patients
- those with end-organ diseases (i.e. heart failure, respiratory failure, hepatic failure, renal failure)
- arrhythmia
- esophageal varix
- pregnant women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PEEP 0 cmH2O
PEEP 0 cmH2O (zero end expiratory pressure, ZEEP)
|
After induction of anesthesia, including insertion of TEE probe, change position from supine to lateral position.
Measure ABGA and cardiac indices for the baseline value.
Apply each PEEP (0, 5, 10 cmH2O) serially at the random order.
6 sequences (0->5->10, 0->10->5, 5->10->0, 5->0->10, 10->5->0, 10->0->5) are equally applied to 6 patients (total 6x6=36 patients) who agreed to this study.
Measure ABGA and cardiac indices after 20 min at each step of peep apply(3 times).
Other Names:
|
|
Experimental: PEEP 5 cmH2O
|
After induction of anesthesia, including insertion of TEE probe, change position from supine to lateral position.
Measure ABGA and cardiac indices for the baseline value.
Apply each PEEP (0, 5, 10 cmH2O) serially at the random order.
6 sequences (0->5->10, 0->10->5, 5->10->0, 5->0->10, 10->5->0, 10->0->5) are equally applied to 6 patients (total 6x6=36 patients) who agreed to this study.
Measure ABGA and cardiac indices after 20 min at each step of peep apply(3 times).
Other Names:
|
|
Experimental: EEP 10 cmH2O
|
After induction of anesthesia, including insertion of TEE probe, change position from supine to lateral position.
Measure ABGA and cardiac indices for the baseline value.
Apply each PEEP (0, 5, 10 cmH2O) serially at the random order.
6 sequences (0->5->10, 0->10->5, 5->10->0, 5->0->10, 10->5->0, 10->0->5) are equally applied to 6 patients (total 6x6=36 patients) who agreed to this study.
Measure ABGA and cardiac indices after 20 min at each step of peep apply(3 times).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the effect of differential PEEP (0, 5, 10 cmH2O) by PaO2(P/F ratio)
Time Frame: 20 minutes after each PEEP apply
|
20 minutes after each PEEP apply
|
|
|
Cardiac function
Time Frame: 20 minutes after each PEEP apply
|
cardiac function : Tei index
|
20 minutes after each PEEP apply
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 29, 2015
Primary Completion (Actual)
May 25, 2016
Study Completion (Actual)
May 25, 2016
Study Registration Dates
First Submitted
June 19, 2015
First Submitted That Met QC Criteria
June 24, 2015
First Posted (Estimate)
June 29, 2015
Study Record Updates
Last Update Posted (Actual)
December 28, 2017
Last Update Submitted That Met QC Criteria
December 26, 2017
Last Verified
December 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 4-2015-0325
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Cancer
-
M.D. Anderson Cancer CenterRecruitingStage III Lung Cancer AJCC v8 | Lung Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingStage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingCaregiver | Stage III Lung Cancer AJCC v7 | Stage I Lung Cancer AJCC v7 | Stage II Lung Cancer AJCC v7 | Stage IB Lung Cancer AJCC v7 | Stage IA Lung Cancer AJCC v7 | Stage IIA Lung Cancer AJCC v7 | Stage IIB Lung Cancer AJCC v7 | Stage IIIA Lung Cancer AJCC v7 | Stage IIIB Lung Cancer AJCC v7United States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung... and other conditionsUnited States
-
Emory UniversityNational Cancer Institute (NCI)TerminatedLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
University of California, San FranciscoMerck Sharp & Dohme LLCWithdrawnLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; MedWaves, IncRecruitingLung Cancer | Lung Cancer Stage I | Lung Cancer Stage II | Stage I Lung Cancer | Stage I - II Primary Lung Cancer | Stage II Lung CancerUnited States
-
WindMIL TherapeuticsBristol-Myers SquibbTerminatedNSCLC | Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer MetastaticUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell CarcinomaUnited States
Clinical Trials on PEEP
-
Gachon University Gil Medical CenterCompletedThe Effect of Positive End Expiratory Pressure (PEEP) During Laparoscopic Cholecystectomy (lapaPEEP)Brain IschemiaKorea, Republic of
-
Al-Azhar UniversityCompletedPulmonary Atelectasis, PostoperativeEgypt
-
Hongpeng LiCompletedTraumatic Brain Injury | Mechanical Ventilation Complication
-
Ankara City Hospital BilkentNot yet recruitingMechanical Ventilation | Postoperative Pulmonary Complications | Impaired Oxygenation
-
University Hospital, Basel, SwitzerlandRecruiting
-
Mansoura UniversityCompletedOne Lung VentilationEgypt
-
Konkuk University Medical CenterUnknownValvular Heart Disease
-
University Hospital, AngersRecruiting
-
University of TriesteCompletedThoracic Surgery | One-lung Ventilation | Respiratory Mechanics | Artificial RespirationItaly